Sponsored Satellite Symposia
Sponsored Satellite Symposia
Thursday, 4 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
20.00 - 21.00
INDUSTRY-SPONSORED WELCOME COCKTAIL
Friday, 5 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
SPONSORED BREAKFAST SYMPOSIUM
08.00 - 09.00
ABIOGEN BREAKFAST SYMPOSIUM - Vitamin D for Muscle-Skeletal Health
Chairperson: Maria Luisa Brandi
‣ Vitamin D for Bone Health René Rizzoli
‣ Vitamin D for Muscle Health Bess Dawson‑Hughes
12.15 - 13.45
UCB SATELLITE LUNCH SYMPOSIUM
12.15 - 13.45
MYLAN SATELLITE LUNCH SYMPOSIUM - Crystalline glucosamine sulfate: exploring the efficacy for potential new indications
Chairpersons: Alberto Migliore, Jean‑Yves Reginster
‣ ESCEO recommendations for clinical trials for hand OA Jean‑Yves Reginster
‣ Hand osteoarthritis: specificities and similarities with knee OA - a short overview Emmanuel Maheu
‣ A new opportunity to treat hand Osteoarthritis: the role of crystalline glucosamine sulfate Sandro Tenti
‣ The challenge of early symptomatic knee osteoarthritis (ESKOA) Alberto Migliore
‣ Cartilage biological markers reaction to immobilization and physical exercise, and potential role of CGS in this context Anna‑Maria Liphardt
‣ Opening of discussion Jean‑Yves Reginster
‣ Conclusion
17.00 - 18.30
KYOWA KIRIN SATELLITE SYMPOSIUM - THE MANY FACES OF RARE BONE DISEASE
Chairpersons: Cyrus Cooper, Christian Roux
‣ Welcome and introductions Cyrus Cooper, Christian Roux
‣ Phosphate wasting disorders in adults: a clinical overview Maria Luisa Brandi
‣ Unexplained fractures in a previously healthy young adult Salvatore Minisola
‣ How to find the needle in the haystack? Lars Rejnmark
‣ A case of mistaken identity: spondyloarthritis or not? Karine Briot
‣ Q&A Christian Roux
‣ Summary and close Cyrus Cooper
17.00 - 18.30
IBSA Satellite Symposium - Differences in the efficacy of various Chondroitin Sulfate preparations: Facts or fantasy?
Chairperson: Jean‑Yves Reginster
‣ Welcome and introduction Jean‑Yves Reginster
‣ Efficacy and tolerance of pharmaceutical-grade Chondroitin Sulfate: What does evidence-based medicine say? Jean‑Yves Reginster
‣ Is there a responder profile to pharmaceutical-grade Chondroitin Sulfate? An analysis of the CONCEPT study Olivier Bruyère
‣ CS pharmaceutical grade and CS nutraceuticals how far are they? Chiara Schiraldi
‣ Discussion and conclusion Jean‑Yves Reginster
Saturday, 6 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
AVAILABLE INDUSTRY-SPONSORED BREAKFAST SYMPOSIUM
08.00 - 09.00
SPONSORED BREAKFAST SESSION
12.15 - 13.45
ELI LILLY SATELLITE LUNCH SYMPOSIUM - 17 Years of Teriparatide: New Insights in the Treatment of Severe Osteoporosis
Chairperson: Thierry Thomas
‣ Welcome and Introduction Thierry Thomas
‣ New Insights on the Mechanism of Action of Teriparatide Erik Fink Eriksen
‣ New Results of Teriparatide in the Treatment of Severe Osteoporosis Adolfo Diez‑Perez
‣ Question and Answers and Close All
12.15 - 13.45
AMGEN SATELLITE LUNCH SYMPOSIUM - IMPROVING OSTEOPOROSIS CARE - GETTING CLOSER TO THE PATIENT
Chairpersons: Eugene McCloskey, Christian Roux
‣ Welcome and introduction Eugene McCloskey, Christian Roux
‣ Estimating the treatment gap in elderly women – a cross-sectional primary care study Socrates Papapoulos
‣ Utility of fracture risk assessment in primary care; identifying the right patient Eugene McCloskey
‣ Managing osteoporosis treatment – challenges and opportunities for primary care physicians Liesbeth Borgermans
‣ Q&A session and meeting close Eugene McCloskey, Christian Roux
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
17.00 - 18.30
AVAILABLE INDUSTRY-SPONSORED SYMPOSIUM
Sunday, 7 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
AVAILABLE INDUSTRY-SPONSORED BREAKFAST SYMPOSIUM
